各國COVID-19兒童疫苗施打資訊一次看

全球多個國家已從今（2021）年6月，陸續規劃兒童或青少年施打COVID-19（嚴重特殊傳染性肺炎、新冠肺炎、武漢肺炎）疫苗，在各國的緊急使用授權（EUA）核准各家疫苗。各國針對孩童施打疫苗規定有許多不同，台灣科技媒體中心將持續蒐集各國政府與媒體等資料，並更新整理以下表格提供參考：

資料最後更新日：2021/09/28

＊兩劑覆蓋率：亦即「完整兩劑疫苗的覆蓋率」，全國比例資料來自「Our World in Data」；不同年齡的比例來自各國衛生機構[9][17][18]

世界衛生組織WHO列入緊急使用清單（EUL）的COVID-19疫苗及日期

研發公司疫苗名稱通過日期

最後更新日：2021/09/24

參考資料

[1] WHO：Is the vaccine safe for children?

[2] Public Health England：COVID-19 vaccination: resources for children and young people

[3] US FDA：Comirnaty and Pfizer-BioNTech COVID-19 Vaccine

[4] US CDC：COVID Data Tracker

[5] JAPAN TIMES：Pfizer approves COVID-19 shots for 12- to 15-year-olds in Japan

[6] JAPAN TIMES：Japan health ministry panel backs lowering Moderna vaccine age limit to 12

[7] CNN：Cuba begins vaccinating children as young as two for Covid-19

[8] CNN：Cuba vaccinates children as young as 2 in strategy to reopen schools, economy

[9] Our World in Data：Coronavirus (COVID-19) Vaccinations

[10] US FDA：Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers)

[11] EU EMA：First COVID-19 vaccine approved for children aged 12 to 15 in EU

[12] EU EMA：COVID-19 vaccine Spikevax approved for children aged 12 to 17 in EU

[13] Bloomberg：Cuba Starts Giving Homegrown Covid Vaccine to Children Aged 2 to 10

[14] Bloomberg：Chile Approves Sinovac Vaccine for Children as Young as Six

[15] Reuters：Chilean health regulator approves CoronaVac use among children over age 6

[16] 毎日新聞社：COVID vaccination quotas increased for 12-and-ups in Japan as cases rise

[17] Johns Hopkins Coronavirus Resource Center：UNDERSTANDING VACCINATION PROGRESS

[18] Our World in Data：Coronavirus (COVID-19) Vaccinations，Share of the population fully vaccinated against COVID-19

[19] WHO：Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process

[20] Instituto Finlay de Vacunas：En más de 62 mil dósis aplicada de #Soberana02 se ha demostrado la seguridad de la vacuna.

[21] Gob.cl：Autoridades dan inicio a vacunación escolar contra COVID-19 en niños de 6 a 11 años

本文經台灣科技媒體中心授權刊登，原文刊載於此

延伸閱讀

• 輝瑞BNT兒童疫苗有望10月供5至11歲施打，莫德納、Novavax研發流感與COVID-19二合一疫苗
• 古巴替2歲幼兒接種自家開發「主權2」疫苗，未公佈試驗數據能推「疫苗外交」嗎？
• 研究：Delta相較於先前的變種病毒，具有結構上的優勢特徵，造成較高的突破性感染機會

責任編輯：蕭汎如
核稿編輯：翁世航